Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:44 am Purchase |
2024-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
PRICE T ROWE ASSOCIATES INC | 3,343,643 5.300% |
2,521,042 (+306.47%) |
Filing History |
| 2025-02-12 09:30 am Purchase |
2024-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
FMR CORP | 6,306,391 10.000% |
1,365,267 (+27.63%) |
Filing History |
| 2024-11-12 10:32 am Purchase |
2024-11-08 | 13G | MoonLake Immunotherapeutics MLTX |
FMR CORP | 4,941,124 7.856% |
1,093,447 (+28.42%) |
Filing History |
| 2024-10-08 6:48 pm Sale |
2024-10-04 | 13D | MoonLake Immunotherapeutics MLTX |
BIOTECHNOLOGY VALUE FUND L P | 19,751,284 31.400% |
-2,000,000 (-9.19%) |
Filing History |
| 2024-03-05 4:59 pm Unchanged |
2024-02-29 | 13D | MoonLake Immunotherapeutics MLTX |
BIOTECHNOLOGY VALUE FUND L P | 21,751,284 34.600% |
0 (Unchanged) |
Filing History |
| 2024-02-15 08:00 am Sale |
2023-12-31 | 13G | Helix Acquisition Corp. HLXA |
Merck Healthcare KGaA | 2,787,509 4.700% |
-542,722 (-16.30%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
Citadel Advisors LLC | 2,034,260 3.400% |
-851,832 (-29.52%) |
Filing History |
| 2024-02-14 3:05 pm Purchase |
2023-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
Chen Bihua | 8,494,151 14.170% |
1,602,051 (+23.24%) |
Filing History |
| 2024-02-09 09:28 am Purchase |
2024-02-08 | 13G | MoonLake Immunotherapeutics MLTX |
FMR CORP | 3,847,677 6.419% |
2,654,677 (+222.52%) |
Filing History |
| 2023-06-30 4:41 pm Unchanged |
2023-06-27 | 13D | MoonLake Immunotherapeutics MLTX |
BIOTECHNOLOGY VALUE FUND L P | 21,751,284 35.800% |
0 (Unchanged) |
Filing History |
| 2023-03-31 4:23 pm Purchase |
2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
Chen Bihua | 6,892,100 17.600% |
6,892,100 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
PRICE T ROWE ASSOCIATES INC | 822,601 2.100% |
822,601 (New Position) |
Filing History |
| 2023-02-14 08:26 am Purchase |
2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
Citadel Advisors LLC | 2,886,092 7.400% |
2,886,092 (New Position) |
Filing History |
| 2023-02-09 12:48 pm Purchase |
2023-02-09 | 13G | MoonLake Immunotherapeutics MLTX |
FMR CORP | 1,193,000 3.230% |
1,193,000 (New Position) |
Filing History |
| 2023-02-09 10:09 am Unchanged |
2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-01-27 06:13 am Unchanged |
2022-12-31 | 13G | Helix Acquisition Corp. HLXA |
Merck Healthcare KGaA | 3,330,231 7.900% |
0 (Unchanged) |
Filing History |
| 2022-08-03 06:17 am Purchase |
2022-08-06 | 13G | Helix Acquisition Corp. HLXA |
Merck Healthcare KGaA | 3,330,231 8.300% |
3,330,231 (New Position) |
Filing History |
| 2022-04-18 4:49 pm Purchase |
2022-04-05 | 13D | MoonLake Immunotherapeutics MLTX |
BIOTECHNOLOGY VALUE FUND L P | 21,751,284 58.900% |
21,751,284 (New Position) |
Filing History |
| 2022-02-14 2:35 pm Sale |
2021-12-31 | 13G | Helix Acquisition Corp. HLXA |
PRICE T ROWE ASSOCIATES INC | 746,862 6.200% |
-40,923 (-5.19%) |
Filing History |
| 2022-02-14 06:12 am Sale |
2021-12-31 | 13G | Helix Acquisition Corp. HLXA |
Citadel Advisors LLC | 686,007 5.800% |
-1,071 (-0.16%) |
Filing History |